Skip to main content
Erschienen in: Annals of Surgical Oncology 11/2010

01.11.2010 | Translational Research and Biomarkers

Prognostic Significance of E-cadherin Expression and Peripheral Blood Micrometastasis in Gastric Carcinoma Patients

verfasst von: Abeer A. Saad, MD, Nahla M. Awed, MD, Nashwa N. A. Abd Elkerim, MD, Dina EL-Shennawy, MD, Marian A. Alfons, MD, Mohamed E. Elserafy, MD, Yaser W. Darwish, MD, Eman M. F. Barakat, MD, Sahar S. Ezz-Elarab, MD

Erschienen in: Annals of Surgical Oncology | Ausgabe 11/2010

Einloggen, um Zugang zu erhalten

Abstract

Background

The primary objective is to evaluate the prognostic value of E-cadherin (E-cad) expression and peripheral blood micrometastasis (PBMM) in gastric carcinoma. Secondary objective is to study the association between these 2 markers and the clinicopathological features of the patients.

Materials and Methods

This study took place at Ain Shams University Hospitals. A total of 30 patients with histologically proven gastric adenocarcinoma after curative surgical resection were enrolled in this study. E-cad expression was assessed in tumor tissue samples. Before the start of adjuvant chemoradiotherapy, fresh blood samples were collected to detect PBMM as indicated by cytokeratin18 mRNA expression using real-time quantitative polymerase chain reaction (RQ-PCR).

Results

Both abnormal E-cad expression and PBMM were significantly associated with lymph node metastasis, TNM stage, and lymphatic invasion. Moreover, PBMM was significantly associated with poor tissue differentiation and vascular invasion (P < .05). We found strong agreement between E-cad expression and presence of PBMM (P = .001). Both cases with altered E-cad expression and cases with positive PPMM showed shorter relapse-free survival (RFS) (P = .003 and <.001, respectively). Cox regression analysis showed that positive PBMM was independent predictor factor for relapse (hazard ratio [HR] = 6.14; 95% confidence interval [95% CI] = 1.06–35.63; P = .04). Cases with positive PBMM showed shorter overall survival (OS) (P = .001).

Conclusions

In conclusion, loss of normal E-cad expression in gastric cancer showed a close correlation with the presence of PBMM. PBMM was associated with poor RFS independent of other clinicopathological features. Additionally, detection of PBMM was a significant indicator of OS, and intensive chemotherapy seems to be indicated for these patients.
Literatur
1.
Zurück zum Zitat Gamboa-Dominguez A, Seidl S, Reyes-Gutierrez E, Hermannstädter C, Quintanilla-Martinez L, Busch R, et al. Prognostic significance of p21WAF1/CIP1, P27Kip1, p53 and E-cadherin expression in gastric cancer. J Clin Pathol. 2007;60:756–61.CrossRefPubMed Gamboa-Dominguez A, Seidl S, Reyes-Gutierrez E, Hermannstädter C, Quintanilla-Martinez L, Busch R, et al. Prognostic significance of p21WAF1/CIP1, P27Kip1, p53 and E-cadherin expression in gastric cancer. J Clin Pathol. 2007;60:756–61.CrossRefPubMed
2.
Zurück zum Zitat Chan AOO. E-cadherin in gastric cancer. World J Gastroenterol. 2006;12:199–203.PubMed Chan AOO. E-cadherin in gastric cancer. World J Gastroenterol. 2006;12:199–203.PubMed
3.
Zurück zum Zitat Takeichi M. Cadherin cell adhesion receptors as a morphogenetic regulator. Science. 1991;251:1451–5.CrossRefPubMed Takeichi M. Cadherin cell adhesion receptors as a morphogenetic regulator. Science. 1991;251:1451–5.CrossRefPubMed
4.
Zurück zum Zitat Xu W, Zhang MW, Huang J, Wang X, Xu SF, Li Y, et al. Correlation between CK18 gene and gastric carcinoma micrometastasis. World J Gastroenterol. 2005;11:6530–4.PubMed Xu W, Zhang MW, Huang J, Wang X, Xu SF, Li Y, et al. Correlation between CK18 gene and gastric carcinoma micrometastasis. World J Gastroenterol. 2005;11:6530–4.PubMed
5.
Zurück zum Zitat Chen XM, Chen GY, Wang ZR, Zhu FS, Wang XL, Zhang X. Detection of micrometastasis of gastric carcinoma in peripheral blood circulation. World J Gastroenterol. 2004;10:804–8.PubMed Chen XM, Chen GY, Wang ZR, Zhu FS, Wang XL, Zhang X. Detection of micrometastasis of gastric carcinoma in peripheral blood circulation. World J Gastroenterol. 2004;10:804–8.PubMed
6.
Zurück zum Zitat Gong YL and Zhou QH. Study progression of molecular diagnosis of lung carcinoma micrometastasis. Zhongguo Feiai Zazhi. 2002;3:75. Gong YL and Zhou QH. Study progression of molecular diagnosis of lung carcinoma micrometastasis. Zhongguo Feiai Zazhi. 2002;3:75.
7.
Zurück zum Zitat Macdonald JS, Smalley SR, Benedetti J, Hundahl SA, Estes NC, Stemmermann GN, et al. Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction. N Engl J Med. 2001;345:725–30.CrossRefPubMed Macdonald JS, Smalley SR, Benedetti J, Hundahl SA, Estes NC, Stemmermann GN, et al. Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction. N Engl J Med. 2001;345:725–30.CrossRefPubMed
8.
Zurück zum Zitat Zhou YN, Xu C-P, Han B, Li M, Qiao L, Fang DC, et al. Expression of E-cadherin and beta-catenin in gastric carcinoma and its correlation with the clinicopathological features and patient survival. World J Gastroenterol. 2002;8:987–93.PubMed Zhou YN, Xu C-P, Han B, Li M, Qiao L, Fang DC, et al. Expression of E-cadherin and beta-catenin in gastric carcinoma and its correlation with the clinicopathological features and patient survival. World J Gastroenterol. 2002;8:987–93.PubMed
9.
Zurück zum Zitat Kaplan EL and Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc. 1958;53:457–81.CrossRef Kaplan EL and Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc. 1958;53:457–81.CrossRef
10.
Zurück zum Zitat Shimoyama Y and Hirohashi S. Expression of E- and P-cadherin in gastric carcinomas. Cancer Res. 1991;51:2185–92.PubMed Shimoyama Y and Hirohashi S. Expression of E- and P-cadherin in gastric carcinomas. Cancer Res. 1991;51:2185–92.PubMed
11.
Zurück zum Zitat Mayer B, Johnson JP, Leitl F, Jauch KW, Heiss MM, Schildberg FW, et al. E-cadherin expression in primary and metastatic gastric cancer: down-regulation correlates with cellular differentiation and glandular disintegration. Cancer Res. 1993;53:1690–5.PubMed Mayer B, Johnson JP, Leitl F, Jauch KW, Heiss MM, Schildberg FW, et al. E-cadherin expression in primary and metastatic gastric cancer: down-regulation correlates with cellular differentiation and glandular disintegration. Cancer Res. 1993;53:1690–5.PubMed
12.
Zurück zum Zitat Wu ZY, Zhan WH, Li JH, He YL, Wang JP, Lan P, et al. Expression of E-cadherin in gastric carcinoma and its correlation with lymph node micrometastasis. World J Gastroenterol. 2005;11:3139–43.PubMed Wu ZY, Zhan WH, Li JH, He YL, Wang JP, Lan P, et al. Expression of E-cadherin in gastric carcinoma and its correlation with lymph node micrometastasis. World J Gastroenterol. 2005;11:3139–43.PubMed
13.
Zurück zum Zitat Kim JH, Park JM, Jung CW, Park SS, Kim SJ, Mok YJ, et al. The significances of lymph node micrometastasis and its correlation with E-cadherin expression in pT1-T3N0 gastric adenocarcinoma. J Surg Oncol. 2008;97:125–30.CrossRefPubMed Kim JH, Park JM, Jung CW, Park SS, Kim SJ, Mok YJ, et al. The significances of lymph node micrometastasis and its correlation with E-cadherin expression in pT1-T3N0 gastric adenocarcinoma. J Surg Oncol. 2008;97:125–30.CrossRefPubMed
14.
Zurück zum Zitat Jung IM, Chung KJ, Kim YA, Kim JE, Heo SC, Ahn YJ, et al. Epstein-Barr virus, beta-catenin, and E-cadherin in gastric carcinomas. J Korean Med Sci. 2007;22:855–61.CrossRefPubMed Jung IM, Chung KJ, Kim YA, Kim JE, Heo SC, Ahn YJ, et al. Epstein-Barr virus, beta-catenin, and E-cadherin in gastric carcinomas. J Korean Med Sci. 2007;22:855–61.CrossRefPubMed
15.
Zurück zum Zitat Chen HC, Chu RY, Hsu PN, Hsu PI, Lu JY, Lai KH, et al. Loss of E-cadherin expression correlates with poor differentiation and invasion into adjacent organs in gastric adenocarcinomas. Cancer Lett. 2003;201:97–106.CrossRefPubMed Chen HC, Chu RY, Hsu PN, Hsu PI, Lu JY, Lai KH, et al. Loss of E-cadherin expression correlates with poor differentiation and invasion into adjacent organs in gastric adenocarcinomas. Cancer Lett. 2003;201:97–106.CrossRefPubMed
16.
Zurück zum Zitat Yonemura Y, Ninomiya I, Kaji M, Sugiyama K, Fujimura T, Tsuchihara K, et al. Decreased E-cadherin expression correlates with poor survival in patients with gastric cancer. Anal Cell Pathol. 1995;8:177–90.PubMed Yonemura Y, Ninomiya I, Kaji M, Sugiyama K, Fujimura T, Tsuchihara K, et al. Decreased E-cadherin expression correlates with poor survival in patients with gastric cancer. Anal Cell Pathol. 1995;8:177–90.PubMed
17.
Zurück zum Zitat Matsunami K, Nakamura T, Oguma H, Kitamura Y, Takasaki K. Detection of bone marrow micrometastasis in gastric cancer patients by immunomagnetic separation. Ann Surg Oncol. 2003;10:171–5.CrossRefPubMed Matsunami K, Nakamura T, Oguma H, Kitamura Y, Takasaki K. Detection of bone marrow micrometastasis in gastric cancer patients by immunomagnetic separation. Ann Surg Oncol. 2003;10:171–5.CrossRefPubMed
18.
Zurück zum Zitat Jawhari A, Jordan S, Poole S, Browne P, Pignatelli M, Farthing MJ. Abnormal immunoreactivity of the E-cadherin-catenin complex in gastric carcinoma: relationship with patient survival. Gastroenterology. 1997;112:46–54.CrossRefPubMed Jawhari A, Jordan S, Poole S, Browne P, Pignatelli M, Farthing MJ. Abnormal immunoreactivity of the E-cadherin-catenin complex in gastric carcinoma: relationship with patient survival. Gastroenterology. 1997;112:46–54.CrossRefPubMed
19.
Zurück zum Zitat Gabbert HE, Mueller W, Schneiders A, Meier S, Moll R, Birchmeier W, et al. Prognostic value of E-cadherin expression in 413 gastric carcinomas. Int J Cancer. 1996;69:184–9.CrossRefPubMed Gabbert HE, Mueller W, Schneiders A, Meier S, Moll R, Birchmeier W, et al. Prognostic value of E-cadherin expression in 413 gastric carcinomas. Int J Cancer. 1996;69:184–9.CrossRefPubMed
Metadaten
Titel
Prognostic Significance of E-cadherin Expression and Peripheral Blood Micrometastasis in Gastric Carcinoma Patients
verfasst von
Abeer A. Saad, MD
Nahla M. Awed, MD
Nashwa N. A. Abd Elkerim, MD
Dina EL-Shennawy, MD
Marian A. Alfons, MD
Mohamed E. Elserafy, MD
Yaser W. Darwish, MD
Eman M. F. Barakat, MD
Sahar S. Ezz-Elarab, MD
Publikationsdatum
01.11.2010
Verlag
Springer-Verlag
Erschienen in
Annals of Surgical Oncology / Ausgabe 11/2010
Print ISSN: 1068-9265
Elektronische ISSN: 1534-4681
DOI
https://doi.org/10.1245/s10434-010-1151-8

Weitere Artikel der Ausgabe 11/2010

Annals of Surgical Oncology 11/2010 Zur Ausgabe

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

CME: 2 Punkte

Prof. Dr. med. Gregor Antoniadis Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

CME: 2 Punkte

Dr. med. Benjamin Meyknecht, PD Dr. med. Oliver Pieske Das Webinar S2e-Leitlinie „Distale Radiusfraktur“ beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

CME: 2 Punkte

Dr. med. Mihailo Andric
Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.